BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 913249)

  • 1. [Treatment of pseudomonas infection with the new ureidopenicillin, azlocillin (author's transl)].
    Helm EB; Ristow W; Shah PM; Schacht P; Stille W
    Dtsch Med Wochenschr; 1977 Aug; 102(34):1211-6. PubMed ID: 913249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the clinical activity of azlocillin. A multicenter study conducted in 14 centers].
    Konopka CA
    Presse Med; 1984 Mar; 13(13):808-11. PubMed ID: 6231600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cefotaxime in septicaemia and severe infections due to multiresistant Gram-negative bacilli (author's transl)].
    Dureux JB; Canton P; Roche G; Weber M; Gérard A
    Nouv Presse Med; 1981 Feb; 10(8):601-6. PubMed ID: 6259602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmakokinetic and clinical studies with azlocillin in paediatrics (author's transl)].
    Weingärtner L; Sitka U; Patsch R; Richter I; Thiemann HH
    Klin Padiatr; 1980 Sep; 192(5):419-29. PubMed ID: 7192337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pediatric pharmacology of azlocilin (author's transl)].
    Sitka U; Weingärtner L; Patsch R; Richter I
    Padiatr Padol; 1979; 14(4):429-40. PubMed ID: 530731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azlocillin and gentamicin in respiratory tract infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Malmborg AS; Alfredsson H; Kusoffsky E; Strandvik B
    Scand J Infect Dis Suppl; 1981; 29():64-9. PubMed ID: 6947407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of infections due to Pseudomonas aeruginosa with carbenicillin ("Pyopen").
    Stratford BC
    Med J Aust; 1968 Nov; 2(20):890-5. PubMed ID: 4973410
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical trials of carbenicillin therapy in infections due to Pseudomonas aeruginosa].
    Malfatti S; Pardini C; Silvi G
    G Mal Infett Parassit; 1971 Nov; 23(11):1063-8. PubMed ID: 5004853
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of azlocillin in the treatment of Pseudomonas urinary infections].
    Canton P
    Presse Med; 1984 Mar; 13(13):830-3. PubMed ID: 6231606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical results with azlocillin (author's transl)].
    Schacht P; Tettenborn D; Hullmann R; Bruck H
    Arzneimittelforschung; 1979; 29(12a):1981-5. PubMed ID: 396929
    [No Abstract]   [Full Text] [Related]  

  • 11. [Carbenicillin. Current data on its use].
    Bertoye A; Woehrle R
    Lyon Med; 1971; 225():Suppl:137-41. PubMed ID: 5564793
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of serious Pseudomonas infections with azlocillin.
    Olive S; Mogabgab WJ; Holmes B; Pollock B; Pauling B; Beville R
    J Antimicrob Chemother; 1983 May; 11 Suppl B():153-8. PubMed ID: 6619026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of Pseudomonas aeruginosa infections in a Children's hospital.
    Abbe JS; Moffet HL
    Antimicrob Agents Chemother (Bethesda); 1970; 10():303-8. PubMed ID: 5000261
    [No Abstract]   [Full Text] [Related]  

  • 14. Azlocillin in cystic fibrosis.
    Malmborg AS; Alfredsson H; Strandvik B
    Isr J Med Sci; 1983 Nov; 19(11):1001-3. PubMed ID: 6662681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monotherapy of Pseudomonas aeruginosa septicemia with azlocillin].
    Godard J; Aubertin J; Borderon JC; Dureux JB; Motin J
    Presse Med; 1984 Mar; 13(13):819-21. PubMed ID: 6231603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobramycin: clinical and microbiological evaluation.
    Schoutens E; Vanderlinden MP; Yourassowsky E
    Int J Clin Pharmacol; 1973 Nov; 8(3):207-15. PubMed ID: 4589328
    [No Abstract]   [Full Text] [Related]  

  • 17. [Perichondritis of the auricula. Prevention of defective healing with azlocillin].
    Ganz H
    HNO; 1982 Nov; 30(11):428-9. PubMed ID: 7161155
    [No Abstract]   [Full Text] [Related]  

  • 18. Pseudomonas infections of the lung treated with azlocillin. Microbiology, pharmacokinetics, clinic.
    Daikos GK; Giamarellou H; Hadjipolydorou K; Kanellakopoulou K
    Arzneimittelforschung; 1979; 29(12a):1976-8. PubMed ID: 120747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of azlocillin in the treatment of Pseudomonas bronchopulmonary infections].
    Arnaud A; Gevaudan MJ; Saadjian M; Dugue P; Charpin J
    Presse Med; 1984 Mar; 13(13):834-7. PubMed ID: 6231607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of cefotaxime against infections (author's transl)].
    Lepeu G; Bertrand A; Armengaud M; Aubertin J
    Nouv Presse Med; 1981 Feb; 10(8):594-7. PubMed ID: 6259600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.